Key result
PI3Kgamma inhibition or deficiency impaired reparative neovascularization, enhanced cardiomyocyte apoptosis, and worsened cardiac function following experimental myocardial infarction.
Why the study?
Does PI3Kgamma inhibition or deficiency impair angiogenesis and healing following experimental myocardial infarction?
Does PI3Kgamma inhibition or deficiency impair angiogenesis and healing following experimental myocardial infarction?
Answers are grounded in this paper and cite their sources.
PI3Kgamma expression and catalytic activity are crucial for reparative neovascularization and healing after myocardial infarction, suggesting that PI3Kgamma inhibitors may have detrimental cardiac effects post-MI.
RATIONALE: Phosphoinositide 3-kinase (PI3K)gamma is expressed in hematopoietic cells, endothelial cells (ECs), and cardiomyocytes and regulates different cellular functions relevant to inflammation, tissue remodeling and cicatrization. Recently, PI3Kgamma inhibitors have been indicated for the treatment of chronic inflammatory/autoimmune diseases and atherosclerosis. OBJECTIVE: We aimed to determine PI3Kgamma contribution to the angiogenic capacity of ECs and the effect of PI3Kgamma inhibition on healing of myocardial infarction (MI). METHODS AND RESULTS: Human umbilical ECs were treated with a selective PI3Kgamma inhibitor, AS605240, or a pan-phosphoinositide 3-kinases inhibitor, LY294002. Both inhibitory treatments and small interfering RNA-mediated PI3Kgamma knockdown strongly impaired ECs angiogenic capacity, because of suppression of the PI3K/Akt and mitogen-activated protein kinase pathways. Constitutive activation of Akt rescued the angiogenic defect. Reparative angiogenesis was studied in vivo in a model of MI. AS605240 did not affect MI-induced PI3Kgamma upregulation, whereas it suppressed Akt activation and downstream signaling. AS605240 strongly reduced inflammation, enhanced cardiomyocyte apoptosis, and impaired survival and proliferation of ECs in peri-infarct zone, which resulted in defective reparative neovascularization. As a consequence, AS605240-treated MI hearts showed increased infarct size and impaired recovery of left ventricular function. Similarly, PI3Kgamma-deficient mice showed impaired reparative neovascularization, enhanced cardiomyocyte apoptosis and marked deterioration of cardiac function following MI. Mice expressing catalytically inactive PI3Kgamma also failed to mount a proper neovascularization, although cardiac dysfunction was similar to wild-type controls. CONCLUSIONS: PI3Kgamma expression and catalytic activity are involved at different levels in reparative neovascularization and healing of MI.
No takes yet. Share an insight, caveat, or question.
Siragusa et al. (2010) studied Myocardial Infarction. PI3Kgamma inhibition (AS605240) or genetic deficiency vs. Control / Wild-type was evaluated on Reparative neovascularization and healing of MI. PI3Kgamma inhibition or deficiency impaired reparative neovascularization, enhanced cardiomyocyte apoptosis, and worsened cardiac function following experimental myocardial infarction.
Synapse has enriched 10 related papers. Consider them for comparative context: